Hyderabad: Pharma major Dr Reddy`s Laboratories has initiated recalling of total five lots of bottles of Ranitidine Hydrochloride tablets, USP, of 150 mg strength, which is used in gastric problems, from the US market due to microbial contamination of non-sterile products. The drug was supplied to three different parties with three different brand names. According to a notification issued by United States Food and Drug Administration, the recalling has been initiated voluntarily by the city-based drug maker and the same was intimated to the drug regulator through a letter on August 2. When contacted, a Dr Reddy`s spokesperson said it is difficult to quantify number of bottles to be called and the financial impact in negligible. Ranitidine Hydrochloride is indicated in gastro- oesophageal reflux disease, treatment of peptic ulcers, treatment of benign gastric ulceration, Zollinger-Ellison syndrome and treatment of duodenal ulceration.
Cure to jet lag comes closer to reality
Dengue cases on the rise in the country